Germany – Open house drug discount agreements for the active ingredient depemokimab, ATC R03DX12
By: Public Purchasing Data Service (responsible for the Procurement Office of the BMI)📍 GermanyOpen
Key Information
| Reference | GB-787194-2026 |
|---|
| Deadline | Oct 31, 2028 12:00 AM |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Germany |
|---|
| Address | Bonn, 53119, Germany |
|---|
| Published | Nov 12, 2026 |
|---|
Description
2. Procedure2.1.procedureTitle: Open house drug discount agreements for the active ingredient depemokimab, ATC R03DX12Description: Conclusion of non-exclusive discount contracts in accordance with Sec...
Full details are available after unlocking this tender.